Co-financing, introduced by GAVI in 2007, means countries share the cost of the vaccines supplied by the GAVI Alliance. The intention is to ensure immunisation programmes are sustainable in the long-term.
Some countries were already co-financing before 2007. But those that were not are now being asked to start co-financing when they introduce new vaccines, and to co-finance existing vaccines beyond the first five years (or equivalent) of GAVI support.
GAVI-eligible countries have been grouped according to their expected ability to pay, and the co-financing levels vary across the different groups.
GAVI will conduct an evaluation of the co-financing policy in 2009. Based on the outcomes of the evaluation, current co-financing levels, country groupings and eligibility criteria are expected to be revised in 2010.
Click here to ask questions about co-financing.